Literature DB >> 17072946

Hepatic progenitor cells in human liver tumor development.

Louis Libbrecht1.   

Abstract

In recent years, the results of several studies suggest that human liver tumors can be derived from hepatic progenitor cells rather than from mature cell types. The available data indeed strongly suggest that most combined hepatocellular-cholangiocarcinomas arise from hepatic progenitor cells that retained their potential to differentiate into the hepatocytic and biliary lineages. Hepatic progenitor cells could also be the basis for some hepatocellular carcinomas and hepatocellular adenomas, although it is very difficult to determine the origin of an individual hepatocellular carcinoma. There is currently not enough data to make statements regarding a hepatic progenitor cell origin of cholangiocarcinoma. The presence of hepatic progenitor cell markers and the presence and extent of the cholangiocellular component are factors that are related to the prognosis of hepatocellular carcinomas and combined hepatocellular-cholangiocarcinomas, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072946      PMCID: PMC4088131          DOI: 10.3748/wjg.v12.i39.6261

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Immunohistochemical evidence for hepatic progenitor cells in liver diseases.

Authors:  Jianyou Tan; Prodromos Hytiroglou; Rosemary Wieczorek; Young NyuN Park; Swan N Thung; Byron Arias; Neil D Theise
Journal:  Liver       Date:  2002-10

2.  Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis.

Authors:  Jennifer A Eleazar; Lorenzo Memeo; Jeffrey S Jhang; Mahesh M Mansukhani; Steven Chin; Soo Mi Park; Jay H Lefkowitch; Govind Bhagat
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

3.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.

Authors:  A Durnez; C Verslype; F Nevens; J Fevery; R Aerts; J Pirenne; E Lesaffre; L Libbrecht; V Desmet; T Roskams
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

Review 4.  Liver cancer: the role of stem cells.

Authors:  M R Alison; M J Lovell
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

5.  Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.

Authors:  Z D Goodman; K G Ishak; J M Langloss; I A Sesterhenn; L Rabin
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

6.  Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment.

Authors:  J H Lee; H J Rim; S Sell
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

7.  Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.

Authors:  P C Wu; J W Fang; V K Lau; C L Lai; C K Lo; J Y Lau
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 8.  Preneoplastic lesions in human hepatocarcinogenesis.

Authors:  Louis Libbrecht; Valeer Desmet; Tania Roskams
Journal:  Liver Int       Date:  2005-02       Impact factor: 5.828

9.  Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma.

Authors:  Shinichi Aishima; Yousuke Kuroda; Yoshiki Asayama; Kenichi Taguchi; Yunosuke Nishihara; Akinobu Taketomi; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2006-03       Impact factor: 3.466

10.  An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.

Authors:  J Haratake; H Hashimoto
Journal:  Liver       Date:  1995-02
View more
  19 in total

Review 1.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

2.  Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.

Authors:  Alphonse E Sirica; Michael H Nathanson; Gregory J Gores; Nicholas F Larusso
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

3.  Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours.

Authors:  Renee G H M van Sprundel; Ted S G A M van den Ingh; Valeer J Desmet; Azeam Katoonizadeh; Louis C Penning; Jan Rothuizen; Tania Roskams; Bart Spee
Journal:  Comp Hepatol       Date:  2010-02-18

4.  Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.

Authors:  Yusuke Ono; Yutaro Hiratsuka; Masaki Murata; Akira Takasawa; Rieko Fukuda; Masanori Nojima; Satoshi Tanaka; Makoto Osanai; Koichi Hirata; Norimasa Sawada
Journal:  Virchows Arch       Date:  2016-07-21       Impact factor: 4.064

Review 5.  Molecular events in hepatic preneoplasia: a review.

Authors:  S W French
Journal:  Exp Mol Pathol       Date:  2010-01-22       Impact factor: 3.362

6.  Expression of the novel protein PTPIP51 in rat liver: an immunohistochemical study.

Authors:  Albrecht Stenzinger; Dietmar Schreiner; Claudia Tag; Monika Wimmer
Journal:  Histochem Cell Biol       Date:  2007-06-06       Impact factor: 4.304

Review 7.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

8.  Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.

Authors:  Liyuan Li; Maoxiang Qian; I-Hsuan Chen; David Finkelstein; Arzu Onar-Thomas; Melissa Johnson; Christopher Calabrese; Armita Bahrami; Dolores H López-Terrada; Jun J Yang; W Andy Tao; Liqin Zhu
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

9.  Human ductal plate and its derivatives express antigens of cholangiocellular, hepatocellular, hepatic stellate/progenitor cell, stem cell, and neuroendocrine lineages, and proliferative antigens.

Authors:  Tadashi Terada
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-12

10.  Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.

Authors:  Patrick Viatour; Ursula Ehmer; Louis A Saddic; Craig Dorrell; Jesper B Andersen; Chenwei Lin; Anne-Flore Zmoos; Pawel K Mazur; Bethany E Schaffer; Austin Ostermeier; Hannes Vogel; Karl G Sylvester; Snorri S Thorgeirsson; Markus Grompe; Julien Sage
Journal:  J Exp Med       Date:  2011-08-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.